Fluidx Medical Technology, Inc.

Fluidx Medical Technology, Inc. is a clinical-stage medical device company with a mission to redefine embolization by developing a new, innovative category of easy-to-use, controllable embolic gels that can treat the widest range of clinical conditions, effectively occluding the smallest vessels up to the largest vessels. The company’s technology will address a wide range of peripheral vascular, interventional oncology, and neurovascular applications, offering simplicity, enhanced visibility, and precise device control during delivery for highly targeted and complete occlusion. 
GPX, ULTRA, and IMPASS Embolic Devices are under development, described and shown for research, educational, and engineering use only, and do not have marketing clearance or approval in any market at this time.